SBSarah E. Brashear

Sarah E. Brashear

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sarah E. Brashear has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Skeletal muscle adaptation to home-based exercise in chronic kidney disease

    by Sarah E. Brashear, Anas Mohamed Sulthan, Denise Chan, Vishal Rao, Gwenaelle Begue, Armin Ahmadi, Tae Youn Kim, Jennifer E. Norman, Usman Rehman, Thomas Jue, et al.

    This study investigates the impact of a home-based, video-monitored 12-wk exercise program, consisting of both endurance and resistance exercise, on skeletal muscle structural remodeling in persons with chronic kidney disease. We found this program increased capillaries and decreased fibroadipogenic progenitors after exercise.

  • Single cell analysis of muscle contracture in cerebral palsy reveals profibrotic and antimyogenic stem cell populations with altered cell-cell interactions

    by Madison W. Stewart, Lin-Ya Hu, Taryn Loomis, Sarah E. Brashear, Lizbeth M. De La Torre, Anas Mohamed Sulthan, Marie Villalba, Jon R. Davids, Yue Wang, Vedant A. Kulkarni, et al.

    The development of skeletal muscle contractures in cerebral palsy is a major component of disability. However, little is known about how contracture influences stem cells. This study is the first to apply single cell RNA sequencing technology to muscle contractures of children with cerebral palsy. The analysis reveals muscle stem cells with reduced myogenic transcription. Critically, a profibrotic subpopulation of fibroadipogenic progenitors is revealed in contracture. Additionally, cell-cell signaling analysis identifies potential therapeutic targets.

  • Open Access

    Kidney disease impairs tendon function in rats

    by Christopher M. T. Hayden, Natalie K. Gilmore, Benjamin Osipov, Sarah E. Brashear, Marc Gorge, Kuang‐Yu Jen, Lucas R. Smith, Blaine A. Christiansen, Baback Roshanravan, Keith Baar

    Spontaneous tendon rupture occurs in a concerning number of individuals with chronic kidney disease (CKD); however almost no data exist regarding CKD‐related tendon pathology. Given that tendon ruptures have a significant impact on health and well‐being we sought to determine whether tendon mechanics are altered by kidney disease in an established rat model of CKD. Male and female Sprague–Dawley rats (age = 8 weeks) were equally divided into a control group (CON, n = 16) and a group fed a diet containing 0.25% adenine to induce kidney disease ( ADI CKD). After 9 weeks, Achilles and tibialis anterior (TA) tendons were excised, and maximum tensile load (MTL), failure stress, modulus and cross‐sectional area (CSA) were measured and evaluated by two‐way ANOVA (main effects: CKD and sex). CKD was confirmed through elevated creatinine (1.99 vs . 0.61 mg/dl, CKD vs . CON, P < 0.001) and blood urea nitrogen (93.4 vs . 21.4 mg/dl, P  < 0.001). Plantar flexor strength was 13% lower in ADI CKD ( P = 0.0214), and femur yield force was decreased by 41% in male ADI CKD ( P  < 0.001). The failure stress of TA tendons was 24% lower in CKD vs . CON ( P = 0.0383). There were no statistically significant differences in TA tendon MTL, modulus or CSA. There were no significant main effects for any parameter for the Achilles; however, post hoc testing following a finding of group‐by‐sex interactions revealed that in females Achilles failure stress was decreased in ADI CKD by 25% ( P = 0.0283). To our knowledge this is the first direct evidence that tendon weakness is caused by kidney disease, providing a model for further evaluating mechanisms and interventions. image Key points: Chronic kidney disease is well known to lead to musculoskeletal dysfunction, such as bone and muscle wasting. Numerous case reports suggest that chronic kidney disease may also predispose patients to catastrophic tendon injuries; however, there are no mechanistic studies or animal models addressing this phenomenon – and thus, no treatments. We determined whether a rat model of chronic kidney disease previously used to study muscle and bone dysfunction (0.25% adenine in the diet) would also cause impaired tendon function. Eight weeks of adenine‐induced kidney disease caused tibialis anterior tendons to tear at 24% lower stress than in control animals, while also decreasing plantar flexor muscle strength by 13% and femur strength by 41% (males only). This is the first experimental evidence for a direct effect of chronic kidney disease on tendon function, establishing a comprehensive multitissue model for future research.


  • Open Access

    Differential encoding of mammalian proprioception by voltage-gated sodium channels

    by Cyrrus M. Espino, Chetan Nagaraja, Serena Ortiz, Jacquelyn R. Dayton, Akash R. Murali, Yanki Ma, Emari L. Mann, Snigdha Garlapalli, Ross P. Wohlgemuth, Sarah E. Brashear, et al.

    Animals requiring purposeful movement for survival are endowed with mechanoreceptors, called proprioceptors, that provide essential sensory feedback from muscles and joints to spinal cord circuits, which modulates motor output. Despite the essential nature of proprioceptive signaling in daily life, the mechanisms governing proprioceptor activity are poorly understood. Here, we identified nonredundant roles for two voltage-gated sodium channels (Na V s), Na V 1.1 and Na V 1.6, in mammalian proprioception. Deletion of Na V 1.6 in somatosensory neurons (Na V 1.6 cKO mice) causes severe motor deficits accompanied by loss of proprioceptive transmission, which contrasts with our previous findings using similar mouse models to target Na V 1.1 (Na V 1.1 cKO ). In Na V 1.6 cKO animals, we observed impairments in proprioceptor end-organ structure and a marked reduction in skeletal muscle myofiber size that were absent in Na V 1.1 cKO mice. We attribute the differential contributions of Na V 1.1 and Na V 1.6 to distinct cellular localization patterns. Collectively, we provide evidence that Na V s uniquely shape neural signaling within a somatosensory modality.


  • Open Access

    Strain-dependent dynamic re-alignment of collagen fibers in skeletal muscle extracellular matrix

    by Ross P. Wohlgemuth, Sathvik Sriram, Kyle E. Henricson, Daryl T. Dinh, Sarah E. Brashear, Lucas R. Smith


  • Open Access

    Differential encoding of mammalian proprioception by voltage-gated sodium channels

    by Cyrrus M. Espino, Chetan Nagaraja, Serena Ortiz, Jacquelyn R. Dayton, Akash R. Murali, Yanki Ma, Emari L. Mann, Snigdha Garlapalli, Ross P. Wohlgemuth, Sarah E. Brashear, et al.

    Animals that require purposeful movement for survival are endowed with mechanosensory neurons called proprioceptors that provide essential sensory feedback from muscles and joints to spinal cord circuits, which modulates motor output. Despite the essential nature of proprioceptive signaling in daily life, the mechanisms governing proprioceptor activity are poorly understood. Here, we have identified distinct and nonredundant roles for two voltage-gated sodium channels (NaVs), NaV1.1 and NaV1.6, in mammalian proprioception. Deletion of NaV1.6 in somatosensory neurons (NaV1.6 cKO mice) causes severe motor deficits accompanied by complete loss of proprioceptive transmission, which contrasts with our previous findings using similar mouse models to target NaV1.1 (NaV1.1 cKO ). In NaV1.6 cKO animals, loss of proprioceptive feedback caused non-cell- autonomous impairments in proprioceptor end-organs and skeletal muscle that were absent in NaV1.1 cKO mice. We attribute the differential contribution of NaV1.1 and NaV1.6 in proprioceptor function to distinct cellular localization patterns. Collectively, these data provide the first evidence that NaV subtypes uniquely shape neurotransmission within a somatosensory modality. Teaser: Voltage gated sodium channels differentially encode mammalian proprioception via distinct cellular localization patterns.


  • Top Cited Papers

    Alignment, cross linking, and beyond: a collagen architect’s guide to the skeletal muscle extracellular matrix

    by Ross P. Wohlgemuth, Sarah E. Brashear, Lucas R. Smith

    The muscle extracellular matrix (ECM) forms a complex network of collagens, proteoglycans, and other proteins that produce a favorable environment for muscle regeneration, protect the sarcolemma from contraction-induced damage, and provide a pathway for the lateral transmission of contractile force. In each of these functions, the structure and organization of the muscle ECM play an important role. Many aspects of collagen architecture, including collagen alignment, cross linking, and packing density affect the regenerative capacity, passive mechanical properties, and contractile force transmission pathways of skeletal muscle. The balance between fortifying the muscle ECM and maintaining ECM turnover and compliance is highly dependent on the integrated organization, or architecture, of the muscle matrix, especially related to collagen. While muscle ECM remodeling patterns in response to exercise and disease are similar, in that collagen synthesis can increase in both cases, one outcome leads to a stronger muscle and the other leads to fibrosis. In this review, we provide a comprehensive analysis of the architectural features of each layer of muscle ECM: epimysium, perimysium, and endomysium. Further, we detail the importance of muscle ECM architecture to biomechanical function in the context of exercise or fibrosis, including disease, injury, and aging. We describe how collagen architecture is linked to active and passive muscle biomechanics and which architectural features are acutely dynamic and adapt over time. Future studies should investigate the significance of collagen architecture in muscle stiffness, ECM turnover, and lateral force transmission in the context of health and fibrosis.


  • Open Access

    Collagen cross-links scale with passive stiffness in dystrophic mouse muscles, but are not altered with administration of a lysyl oxidase inhibitor

    by Sarah E. Brashear, Ross P. Wohlgemuth, Lin-Ya Hu, Elias H. Jbeily, Blaine A. Christiansen, Lucas R. Smith

    In Duchenne muscular dystrophy (DMD), a lack of functional dystrophin leads to myofiber instability and progressive muscle damage that results in fibrosis. While fibrosis is primarily characterized by an accumulation of extracellular matrix (ECM) components, there are changes in ECM architecture during fibrosis that relate more closely to functional muscle stiffness. One of these architectural changes in dystrophic muscle is collagen cross-linking, which has been shown to increase the passive muscle stiffness in models of fibrosis including the mdx mouse, a model of DMD. We tested whether the intraperitoneal injections of beta-aminopropionitrile (BAPN), an inhibitor of the cross-linking enzyme lysyl oxidase, would reduce collagen cross-linking and passive stiffness in young and adult mdx mice compared to saline-injected controls. We found no significant differences between BAPN treated and saline treated mice in collagen cross-linking and stiffness parameters. However, we observed that while collagen cross-linking and passive stiffness scaled positively in dystrophic muscles, collagen fiber alignment scaled with passive stiffness distinctly between muscles. We also observed that the dystrophic diaphragm showed the most dramatic fibrosis in terms of collagen content, cross-linking, and stiffness. Overall, we show that while BAPN was not effective at reducing collagen cross-linking, the positive association between collagen cross-linking and stiffness in dystrophic muscles still show cross-linking as a viable target for reducing passive muscle stiffness in DMD or other fibrotic muscle conditions.


  • Open Access

    Collagen content and cross-links scale with passive stiffness in dystrophic mouse muscles, but are not altered with administration of collagen cross-linking inhibitor beta-aminopropionitrile

    by Sarah E. Brashear, Ross P. Wohlgemuth, Lin-Ya Robert Hu, Elias H. Jbeily, Blaine A. Christiansen, Lucas Robert Smith

    In Duchenne muscular dystrophy (DMD), a lack of functional dystrophin leads to myofiber instability and progressive muscle damage that results in fibrosis. While fibrosis is primarily characterized by an accumulation of extracellular matrix (ECM) components, there are changes in ECM architecture during fibrosis that relate more closely to functional muscle stiffness. One of these architectural changes in dystrophic muscle is collagen cross-linking, which has been shown to increase the passive muscle stiffness in models of fibrosis including the mdx mouse, a model of DMD. We tested whether the intraperitoneal injections of beta-aminopropionitrile (BAPN), an inhibitor of the cross-linking enzyme lysyl oxidase, would reduce collagen cross- linking and passive stiffness in young and adult mdx mice compared to saline-injected controls. We found no significant differences between BAPN treated and saline treated mice in collagen cross-linking and stiffness parameters. However, we observed that while collagen cross-linking and passive stiffness scaled positively in dystrophic muscles, collagen fiber alignment scaled with passive stiffness distinctly between muscles. We also observed that the dystrophic diaphragm showed the most dramatic fibrosis in terms of collagen content, cross-linking, and stiffness. Overall, we show that while BAPN was not effective at reducing collagen cross- linking, the positive association between collagen cross-linking and stiffness in dystrophic muscles still show cross-linking as a viable target for reducing passive muscle stiffness in DMD or other fibrotic muscle conditions. Key Points: BAPN did not reduce collagen cross-linking or passive stiffness in any muscle Collagen cross-links scaled with passive stiffness in dystrophic muscles The mdx diaphragm showed the most dramatic fibrosis related to collagen content, cross- linking, and passive stiffness Collagen fiber alignment scales with passive stiffness differently between muscles